Jasper Therapeutics Announces Research Collaboration With AVROBIO To Evaluate JSP191 As Conditioning Agent In Clinical Studies Of Ex Vivo Lentiviral Gene Therapy
Jasper Therapeutics, Inc. (NASDAQ:JSPR), a biotechnology company focused on hematopoietic stem cell therapeutics, today announced that it has entered into a non-exclusive research collaboration with AVROBIO, Inc. to